Podcasts about American Medical Association

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from February 28-March 6, 2026.

Ted Joyce is a Professor of Economics at Baruch College and the Graduate Center, the City University of New York and a Research Associate in the National Bureau of Economic Research's program in Health Economics. He has published extensively in the area economic demography and reproductive health policy.  His work on abortion policy has appeared in the Journal of Political Economy, New England Journal of Medicine, the Journal of the American Medical Association, the Journal of Human Resources and the Review of Economics and Statistics. His most recent work is on the evaluation of programs to improve the academic outcomes of low-income students in higher-education. Dr. Joyce is on the Editorial Board for the Journal of Policy Analysis and Management. Part 2 The discussion included the following topics: the speed at which change can occur; AI impact on higher education institutions and academic health science centers; trends regarding how AI and online learning might influence one another; and emerging ethical questions that must be addressed.    

What's on your mind? Let CX Passport know...Gloria Gupta leads CX transformation at the American Medical Association.Not a small lift. Not a short-term initiative.A 200-year-old institution.450 million in revenue.Physicians as customers.Patients as the ultimate impact.In this episode, Gloria shares what it really takes to unify service, build enterprise CX, and make customer experience a measurable attribute of brand and culture.5 Key Insights• The AMA's primary customer is the physician … but the physician's customer is the patient• CX transformation began by unifying service into one omnichannel team serving 98% of AMA service interactions• More than 900 improvements have been implemented across the enterprise, many of them significant• 400 employees are directly involved in CX … one in four across the organization• The shared mission: identify and remove customer frictionCHAPTERS00:00 Intro and Rick's personal AMA connection02:00 Who is the AMA customer?04:00 Why CX matters at a 200-year-old institution08:00 Healthcare evolution … EHRs, COVID, telehealth, and AI13:30 Unifying service across the enterprise17:00 Authentication friction and enterprise CX launch20:00 Building trust through measurable wins22:30 First Class Lounge26:50 900 improvements and aftercare strategy30:30 AI, policy, and the future of healthcare CX33:00 Real data, real outcomes, real collaborationConnect with GloriaLinkedIn: https://www.linkedin.com/in/gloria-gupta-rdh-ms-fcxp-4760939/Listen: https://www.cxpassport.comWatch: https://www.youtube.com/@cxpassportNewsletter: https://cxpassport.kit.com/signupI'm Rick Denton and I believe the best meals are served outside and require a passport.Disclaimer: This podcast is for informational and entertainment purposes only. The views and opinions expressed are those of the hosts and guests and should not be taken as legal, financial, or professional advice. Always consult with a qualified attorney, financial advisor, or other professional regarding your specific situation. The opinions expressed by guests are solely theirs and do not necessarily represent the views or positions of the host(s).

In this very fun and information-packed conversation with Dr Iman Bar, we explore the powerful world of peptides what they are, how they work, and how they may support healing, gut health, beauty, and longevity. This conversation IS everything you have wanted to know about peptides. Peptides are rapidly gaining attention in the worlds of functional medicine, performance health, and regenerative support. But what do they actually do in the body? In this episode, we break it all down in a practical and accessible way. We discuss: ✔ What peptides are and how they work in the body ✔ The most popular therapeutic peptides and their roles ✔ Where peptides are made and whether gut health impacts peptide production ✔ How long it typically takes to see results ✔ Weight-related peptide therapies ✔ Complementary therapies like red light support ✔ Emerging peptide research we're excited about ✔ The so-called “Wolverine peptides” and beauty / glow peptides ✔ Oral peptides like BPC-157 and their connection to gut healing ✔ How peptides may support different conditions including: – pain and injury recovery – autoimmune conditions – back pain (KPV) – inflammatory issues (TB4) – bone health concerns like osteoporosis – hormone-related conditions such as endometriosis And lots more. Whether you're new to peptides or already curious about their role in healing and longevity, this conversation offers a grounded look at how these compounds are being used today. Dr. Iman Bar has been a practicing physician since 1990. She began her postgraduate studies in Hematology-Oncology, culminating in a fellowship specializing in stem cell therapy. In 2002, Dr. Bar pioneered the first concierge medical practice in Newport Beach, Newport Concierge Medical. Her dedication in this field earned her numerous accolades, including the prestigious "Top Doctor" honor from the American Medical Association. She offers a variety of advanced modalities, including peptide therapy, hormone replacement, and stem cell therapy. In 2022, she further extended her commitment to cutting-edge medicine by launching the Stem Cell & Longevity Center in Newport Beach. Connect with Dr Br here; ‪@StemCellClinicOC‬ Website; https://www.drbarx.com/ Instagram; / barxmd Facebook; / drbarx

AI and the future of journalism In February, "Ideastream Explores: Artificial Intelligence" covered the myriad ways AI is rapidly evolving and changing our lives. It's impacting how students learn, reshaping the workforce, and we're learning more and more about the environmental costs of data centers and the massive processing power needed for generative AI programs. Ideastream hosted a "Sound of Ideas Community Tour" at the Idea Center and took part in another live event as well, about the intersection of journalism and artificial intelligence and concerns the public has about how we might be using it and what guardrails we're setting in place. The Akron Press Club has pulled together a panel today to talk about the choices newsroom are making and what the next generation of journalists are being taught about AI. Guests: - Andrew Meyer, Deputy Editor, Ideastream Public Media - Phil Trexler, Editor-in-Chief, The Marshall Project - Cleveland - Mizell Stewart, Professor-in-Residence, Kent State University Colorectal Cancer Rates Colorectal cancer is now the leading cause of cancer deaths among people younger than 50 in the United States, according to the Journal of the American Medical Association. The recent deaths of actors James Van Der Beek and Catherine O'Hara have brought renewed attention to the disease. While most cases still occur in people over 50, rates among younger adults are rising. Screening guidelines from the American Cancer Society adopted in 2018 now recommend that average-risk adults begin screening at 45 instead of 50. Colorectal cancer is highly treatable when detected early, and experts say screening options, including colonoscopies and at-home stool tests, are saving lives. Guests: - Joshua Sommovilla, M.D., Colon and Rectal Surgical Oncologist, Cleveland Clinic - Mengdan Xie, M.D., Gastroenterology, MetroHealth - Amy Fogerty, Teacher, Shaker Heights High School

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from February 21-27, 2026.

Dr. Frank Dumont is Executive Medical Director at Virta Health, where he leads medical strategy to advance safe, scalable metabolic care. A longtime internal medicine physician at Estes Park Medical Center, he previously directed its Wellness Service Line. A Fellow of the American College of Physicians, Dr. Dumont has also served in leadership roles with the Colorado Medical Society and the American Medical Association. In this episode, Drs. Brian and Frank talk about… (00:00) Intro (04:03) How Dr. Frank's personal health issues and professional experiences as a doctor led him to adopt a metabolic health approach to healing himself and his patients (10:41) Exercise, nutrition, and de-prescribing  (14:22) Fat adaptation and fasting (24:09) Virta's peer-reviewed publications and long-term data (30:09) The positive cascading effect on holistic health of metabolic lifestyle interventions (36:25) Social support and mental health (44:41) Dr. Frank's experience leaving a standard medical practice and becoming a metabolic health practitioner (52:22) Moral injury and physician burnout in the standard medical care system (54:05) Employe wellness and metabolic health care (01:01:01) Outro/plugs For more information, please see the links below. Thank you for listening! Links: Please consider supporting us on Patreon: https://www.lowcarbmd.com/   Dr. Frank Dumont: Virta Health: https://www.virtahealth.com/ X: https://x.com/FrankDumont Linkedin: https://www.linkedin.com/in/frank-d-dumont-46aa00b7/ Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author Dr. Tro Kalayjian:  Website: https://toward.health Twitter: https://twitter.com/DoctorTro IG: https://www.instagram.com/doctortro/ Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.  Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://toward.health/community/

This week, Oz, Fluent and Euphonic salute the new Black president of the American Medical Association; Oz urges you to call your mother; The Boys discuss the life and achievements of Rev. Jesse Jackson and actor Eric Dane; Thoughts and opinions on the Netflix documentary about the underbelly of America's Next Top Model. Plus, your listener letters and the Top 3 STFUs. Pour Up! Song of the Week: Yo Trane- "Brandy Sippin"

EPISODE SUMMARY In this episode, Arundhati Parmar interviews Shalin Shah, CEO of Marius Pharmaceuticals, about Testosterone Replacement Therapy (TRT) and the long-standing regulatory classification that places testosterone as a Schedule III controlled substance. Shah explains that testosterone was scheduled in 1990 following Olympic doping scandals — despite opposition at the time from the FDA, DEA, and the American Medical Association. More than 30 years later, he argues that the regulatory framework no longer reflects current clinical evidence and may be doing more harm than good. The conversation explores: The scientific evidence surrounding cardiovascular and prostate safety The differences between injectable and oral testosterone therapies The stigma and logistical barriers created by controlled substance status How GLP-1 drugs intersect with hormone health and muscle preservation The possibility of expanding testosterone therapy access to women Whether the current regulatory environment may revisit testosterone scheduling At its core, this episode examines whether testosterone is being regulated based on outdated controversy rather than modern clinical science — and what that means for patients navigating care today. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com  https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ KEYWORDS Testosterone Replacement Therapy TRT regulation Schedule III classification Controlled substances Hormone therapy stigma Men's health Women's hormone therapy TRAVERSE study Cardiovascular risk Prostate cancer risk Oral testosterone Injectable testosterone Hematocrit levels GLP-1 muscle loss Hypogonadism FDA regulation Healthcare policy Hormone optimization   EPISODE HIGHLIGHTS 00:00–01:40 - Why testosterone became a Schedule III controlled substance in 1990 01:40–02:30 - Political backlash after Olympic doping scandals 02:30–03:56 - Testosterone as the only controlled hormone 03:56–04:58 - The physiologic role of testosterone across multiple organ systems 04:58–06:19 - Cardiovascular and prostate cancer risk: What the TRAVERSE study showed 06:19–07:04 - Physiologic vs. supraphysiologic dosing 07:04–08:49 - How controlled status creates stigma and access barriers 08:49–10:10 - Provider tracking, pharmacy hurdles, and patient friction 10:10–11:48 - Would deregulation increase abuse or doping? 11:48–13:20 - GLP-1 drugs, rapid weight loss, and muscle preservation 13:20–15:08 - Testosterone in women: The overlooked half of the population 15:08–16:22 - Injectable vs oral TRT: Mimicking natural diurnal rhythms 16:22–17:40 - Hematocrit elevation differences between injections and oral therapy 17:40–19:07 - Side effect profiles and hormone signaling differences 19:07–20:32 - Go-to-market strategy: Cash pay vs insurance coverage 20:32–21:24 - Stigma among payers and barriers to reimbursement 21:24–22:43 - Expanding label indications and idiopathic hypogonadism 22:43–22:22 - Could the current administration reconsider testosterone scheduling?  

The gap between vaccine science and vaccine policy has been widening under Health Secretary Robert F. Kennedy Jr. Now, the American Medical Association and the Vaccine Integrity Project, based at the University of Minnesota, have announced that they are partnering to create their own vaccine review process, effectively creating a parallel system to the CDC's. Host Ira Flatow talks with Michael Osterholm, executive director of the Vaccine Integrity Project, about the role of this new review panel.Guest: Dr. Michael Osterholm is the director of the Center for Infectious Disease Research and Policy and executive director of the Vaccine Integrity Project at the University of Minnesota.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Episode 213: HIV PrEP Review H. Nicole Magaña, medical student, reviews the history of PrEP and outlines the currently FDA-approved medications used for HIV prevention. Dr. Arreaza provides additional perspective on long-acting injectable options, including how quickly they begin to protect patients after initiation.   Written by Nicole Magana, MSIV, American University of the Caribbean. Comments and edits by Hector Arreaza, MD. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice. Pre-exposure prophylaxis for HIV. Previous episodes related to HIV:  -Episode 67, HIV history (September 2021) -Episode 68, HIV transmissibility (October 2021) -Episode 70 (October 2021), HIV prevention (including HIV Prep with oral medications) -Episode 98 (June 2022), we introduced Apretude, the first injectable for HIV PrEP. Apretude was approved in December 2021.  What is Pre-Exposure prophylaxis (PrEP)? Pre-exposure prophylaxis, or PrEP, is the use of antiretroviral medications taken by individuals who are HIV-negative to prevent HIV acquisition. There are 30,000 new HIV infections annually in the US.  How effective is it? When taken as prescribed, PrEP is highly effective at reducing the risk of HIV transmission through sexual exposure and injection drug use. Patients who are adherent to PrEP can lower their risk of contracting HIV by 99%. The effectiveness of oral PrEP is highly adherence dependent. In trials with 70% adherence, the relative risk of HIV acquisition was 0.27, compared to 0.51 with 40-70% adherence and no significant benefit with adherence ≤40%. How does PrEP work? PrEP works by maintaining therapeutic drug levels in the bloodstream and in target tissues. If HIV exposure occurs, viral replication is inhibited, preventing the establishment of infection. Brief History of PrEP. The concept of PrEP originated from early animal studies demonstrating that antiretroviral medications could prevent retroviral transmission when administered before exposure. In 2010, the iPrEx trial showed that daily oral tenofovir disoproxil fumarate (known as Truvada) with emtricitabine significantly reduced HIV acquisition among men who have sex with men and transgender women. This was the first large clinical trial to demonstrate the effectiveness of PrEP. In 2012, the FDA approved oral Truvada, which is TDF/FTC (tenofovir disoproxil and emtricitabine) for HIV prevention. Since then, additional studies have expanded indications and introduced new formulations, including long-acting injectable options. Who Should Be Offered PrEP? PrEP should be considered for any HIV-negative individual at increased risk of HIV acquisition, including Men who have sex with men, transgender individuals, heterosexual men and women with an HIV-positive partner, individuals with recent bacterial sexually transmitted infections, people who inject drugs, individuals engaging in condomless sex with partners of unknown HIV status. Remember that PrEP should be offered in a nonjudgmental, patient-centered manner, make it a safe space to talk openly about prevention of HIV.  Available HIV PrEP Options. Daily Oral PrEP: There are 2 formulations of Tenofovir. There is Tenofovir disoproxil fumarate (TDF)/ Truvada and Tenofovir alafenamide (TAF)/ Descovy. Each is available in a tablet combined with Emtricitabine a nucleoside reverse transcriptase inhibitor. Truvada: It is approved for all populations at risk through sexual exposure or injection drug use. Something to look out for before starting this medication is for pre-existing CKD. Do not give to patients who have an estimated glomerular filtration rate of less than 60 mL/min. (6) Descovy: This option is approved for men who have sex with men and transgender women but is not approved for individuals at risk through receptive vaginal sex. It has less impact on renal function and bone mineral density compared to Truvada. It can be used in moderately reduced kidney function (GFR between 30-60 mL/min). Truvada and Descovy are taken orally once a day.  After patients start taking these medications, when are they considered to be protected?  Nicole: With daily oral PrEP, guidelines differ with WHO and International Aids Society-USA stating it takes about 7 days, while CDC states 21 days to allow for adequate concentration in tissues (1). Adherence is critical for efficacy. Injectable HIV PrEP. In 2021, the FDA approved the first Injectable PrEP option Long-acting cabotegravir (CAB-LA)- known on the market as Apretude. Cabotegravir is an integrase strand transfer inhibitor administered as an intramuscular injection.Dosing consists of an initial injection, a second injection one month later, and then maintenance injections every two months (1). Another option is Lenacapavir (Yeztugo). The Yeztugo as a pre-exposure prophylaxis (PrEP) for HIV in Oct 2024. Yeztugo is the first and only FDA-approved HIV prevention treatment that requires just two injections per year, offering a long-acting option for people who weigh at least 35kg. It is given as 2 injections every 6 months. First dose is given with 2 tablets on Day 1 and Day 2, then every 6 months 2 injections on the same day. Clinical trials, including HPTN 083 and HPTN 084, demonstrated that injectable cabotegravir is superior to daily oral PrEP in preventing HIV infection. This advantage is largely due to improved adherence rather than differences in intrinsic drug potency. There have been no head-to-head comparisons between Yeztugo and Apretude, but they are both very effective. Apretude starts protecting 7 days after the first dose, and Yeztugo starts protecting 2 hours after Day 2 (if patient takes the oral loading dose) or 3-4 weeks if no oral load is taken. Injectable PrEP is particularly beneficial for patients who struggle with daily pill adherence, have trouble swallowing pills, prefer a discreet option, have difficulty storing their medication or have renal or bone disease that limits the use of tenofovir-based regimens like Truvada and Descovy (6). In one unpublished report by Medline, patients who received Apretude had an increase in bone mineral density compared to those who received Truvada (1). Tests prior to starting PrEP. Before initiating PrEP, patients must be confirmed to be HIV-negative. Baseline evaluation includes HIV testing with a fourth-generation antigen/antibody assay, HIV RNA testing if acute infection is suspected, renal function testing for oral PrEP, Hepatitis B screening, sexually transmitted infection screening, and pregnancy testing when appropriate. PrEP should not be started in individuals with known or suspected acute HIV infection. Monitoring for patients on HIV PrEP. Monitoring typically includes HIV testing every 2 to 3 months, STI screening every 3 to 6 months, renal function monitoring for those on oral PrEP (tenofovir- based), ongoing adherence and risk-reduction counseling. And for injectable PrEP, adherence to the injection schedule is essential, as delayed dosing may increase the risk of resistance if HIV infection occurs. HIV PrEP is not a prevention for other STIs. Screening for STIs and counseling about prevention is essential. Breakthrough HIV infections on PrEP are rare and most often associated with poor adherence or delayed diagnosis. Truvada is more studied in all populations and is considered safe during pregnancy and breastfeeding. There is less data regarding the injectable option in patients who are pregnant, may become pregnant, or whose primary risk factor is injection drug use (1). Injectable PrEP provides an important alternative for patients with chronic kidney disease and bone disease (1). Key Takeaway Pre-exposure prophylaxis is a safe, effective, and evidence-based strategy for HIV prevention. With both daily oral and long-acting injectable options available, PrEP can be individualized to meet patient needs. Normalizing PrEP discussions in clinical practice is essential to reducing new HIV infections and advancing public health goals.  Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week!  References: Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel. The Journal of the American Medical Association. 2025. Gandhi RT, Landovitz RJ, Sax PE, et al. Long-Acting Lenacapavir Acts as an Effective Preexposure Prophylaxis in a Rectal SHIV Challenge Macaque Model. The Journal of Clinical Investigation. 2023. Bekerman E, Yant SR, VanderVeen L, et al. Pharmacokinetics and Safety of Once-Yearly Lenacapavir: A Phase 1, Open-Label Study. Lancet. 2025. Jogiraju V, Pawar P, Yager J, et al.

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from February 14-20, 2026.

Ted Joyce is a Professor of Economics at Baruch College and the Graduate Center, the City University of New York and a Research Associate in the National Bureau of Economic Research's program in Health Economics. He has published extensively in the area economic demography and reproductive health policy.  His work on abortion policy has appeared in the Journal of Political Economy, New England Journal of Medicine, the Journal of the American Medical Association, the Journal of Human Resources and the Review of Economics and Statistics. His most recent work is on the evaluation of programs to improve the academic outcomes of low-income students in higher-education. Dr. Joyce is on the Editorial Board for the Journal of Policy Analysis and Management. Part 1 The discussion included the following topics: does tension exist between AI and online learning; whether AI transforms online learning into something more effective; role played by AI in measuring student performance; and determining certainty that the work produced by a student is by that individual.      

Segment 1 • How Oprah has contributed to the disintegration of the family. • A bestselling self-help movement is convincing millions to cut off their parents in the name of “freedom”—and it's reshaping families everywhere. • The explosive rise of “ghosting your parents” isn't random, but a consequence of a predominant worldview. Segment 2 • A shocking study reveals 67 million Americans are estranged from family, with many saying it's for the sake of their mental health. • Social media and therapeutic language are redefining normal disagreements as “toxic abuse”. • The Bible offers a radically different framework: the people who frustrate you the most may be God's primary tool to sanctify you. Segment 3 • The painful question every ghosted parent asks: should you fight for the relationship—or let them walk away? • The hidden parenting mistake that unintentionally pushes adult children further away. • Gen Z's disturbing reinterpretation of Jesus reveals how cultural programming is reshaping how the next generation sees Christ. Segment 4 • A governor's executive order banning “conversion therapy” could criminalize basic biblical counseling and gospel conversations. • Legal definitions are expanding so broadly that simply calling sin “sin” could be labeled harmful or illegal. • The American Medical Association quietly reverses course on gender procedures for minors—raising urgent questions about truth, authority, and agenda. ___ Thanks for listening! Wretched Radio would not be possible without the financial support of our Gospel Partners. If you would like to support Wretched Radio we would be extremely grateful. VISIT https://fortisinstitute.org/donate/ If you are already a Gospel Partner we couldn't be more thankful for you if we tried!

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-472 Overview: The transition from hospital to home is a valuable period for patients and clinicians. In this episode, we discuss which patients require follow-up, what should be reviewed during these appointments, and when follow-up should take place to help improve patient outcomes. Episode resource links: Anderson, T. S., Herzig, S. J., Marcantonio, E. R., Yeh, R. W., Souza, J., & Landon, B. E. (2024, April). Medicare transitional care management program and changes in timely postdischarge follow-up. In JAMA Health Forum (Vol. 5, No. 4, pp. e240417-e240417). American Medical Association. Anderson, T. S., Wilson, L. M., Wang, B. X., Steinman, M. A., Schonberg, M. A., Marcantonio, E. R., & Herzig, S. J. (2025). Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study. Journal of general internal medicine, 1-10.   Balasubramanian, I., Andres, E. B., & Malhotra, C. (2025). Outpatient follow-up and 30-day readmissions: a systematic review and meta-analysis. JAMA Network Open, 8(11), e2541272-e2541272. Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-472 Overview: The transition from hospital to home is a valuable period for patients and clinicians. In this episode, we discuss which patients require follow-up, what should be reviewed during these appointments, and when follow-up should take place to help improve patient outcomes. Episode resource links: Anderson, T. S., Herzig, S. J., Marcantonio, E. R., Yeh, R. W., Souza, J., & Landon, B. E. (2024, April). Medicare transitional care management program and changes in timely postdischarge follow-up. In JAMA Health Forum (Vol. 5, No. 4, pp. e240417-e240417). American Medical Association. Anderson, T. S., Wilson, L. M., Wang, B. X., Steinman, M. A., Schonberg, M. A., Marcantonio, E. R., & Herzig, S. J. (2025). Medication Errors and Gaps in Medication Discharge Planning for Hospitalized Older Adults: A Prospective Cohort Study. Journal of general internal medicine, 1-10.   Balasubramanian, I., Andres, E. B., & Malhotra, C. (2025). Outpatient follow-up and 30-day readmissions: a systematic review and meta-analysis. JAMA Network Open, 8(11), e2541272-e2541272. Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

The American Society of Plastic Surgeons has released an updated statement recommending against gender surgeries for anyone under the age of 18. While the American Medical Association has issued a similar stance, other organizations—including the American Academy of Pediatrics—argue that healthcare decisions should remain between families and doctors, and that surgical options should stay on the table for minors. Earlier this week, plastic surgeon and star of Netflix's Skin Decision: Before and After, Dr. Sheila Nazarian, joined FOX News Rundown host Dave Anthony to explain why many in her field believe minors should not "go under the knife" for transition procedures. Dr. Nazarian raised alarms over the lack of long-term data regarding the effectiveness of these treatments, emphasizing her belief that evidence-based medicine must be the sole guide for treating gender dysphoria in children. She also discussed the professional risks of speaking out, noting that many in the medical community fear political backlash for questioning current standards of care. We often have to cut our interviews short during the week, but we thought you might like to hear this conversation in its entirety. Today on a Fox News Rundown Extra, we share our full interview with plastic surgeon Dr. Sheila Nazarian. Learn more about your ad choices. Visit podcastchoices.com/adchoices

The American Society of Plastic Surgeons has released an updated statement recommending against gender surgeries for anyone under the age of 18. While the American Medical Association has issued a similar stance, other organizations—including the American Academy of Pediatrics—argue that healthcare decisions should remain between families and doctors, and that surgical options should stay on the table for minors. Earlier this week, plastic surgeon and star of Netflix's Skin Decision: Before and After, Dr. Sheila Nazarian, joined FOX News Rundown host Dave Anthony to explain why many in her field believe minors should not "go under the knife" for transition procedures. Dr. Nazarian raised alarms over the lack of long-term data regarding the effectiveness of these treatments, emphasizing her belief that evidence-based medicine must be the sole guide for treating gender dysphoria in children. She also discussed the professional risks of speaking out, noting that many in the medical community fear political backlash for questioning current standards of care. We often have to cut our interviews short during the week, but we thought you might like to hear this conversation in its entirety. Today on a Fox News Rundown Extra, we share our full interview with plastic surgeon Dr. Sheila Nazarian. Learn more about your ad choices. Visit podcastchoices.com/adchoices

The American Society of Plastic Surgeons has released an updated statement recommending against gender surgeries for anyone under the age of 18. While the American Medical Association has issued a similar stance, other organizations—including the American Academy of Pediatrics—argue that healthcare decisions should remain between families and doctors, and that surgical options should stay on the table for minors. Earlier this week, plastic surgeon and star of Netflix's Skin Decision: Before and After, Dr. Sheila Nazarian, joined FOX News Rundown host Dave Anthony to explain why many in her field believe minors should not "go under the knife" for transition procedures. Dr. Nazarian raised alarms over the lack of long-term data regarding the effectiveness of these treatments, emphasizing her belief that evidence-based medicine must be the sole guide for treating gender dysphoria in children. She also discussed the professional risks of speaking out, noting that many in the medical community fear political backlash for questioning current standards of care. We often have to cut our interviews short during the week, but we thought you might like to hear this conversation in its entirety. Today on a Fox News Rundown Extra, we share our full interview with plastic surgeon Dr. Sheila Nazarian. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from February 7-13, 2026.

Part 2 of a 2-part episode on Information Blocking From a December 2025 WEDI virtual spotlight, a panel of health IT leaders break down the current state and the future of regarding information blocking, and how organizations can stay compliant while moving interoperability forward. The panel: Rebekah Fiehn, Strategic Partnership Developer, American Dental Association Andrew Tomlinson, Senior Director, Regulatory & International Affairs, AHIMA Arna Meyer, Technical Product Manager, Stedi Alisa Kuehn, VP, General Counsel & Privacy Officer, Indiana Health Information Exchange Chelsea Arnone, Director, Federal Affairs, CHIME Sasha TerMaat, EHRA's Information Blocking Compliance Task Force The moderator is Jeff Coughlin, Director, Federal Affairs, American Medical Association

The medical community is finally realizing that transgender surgeries are harming America’s children. Recently, both the American Society of Plastic Surgeons and the American Medical Association released statements recommending gender-affirming surgeries be delayed until adulthood, but what does this mean for the issue as a whole? Is change happening? Host Casey Harper is joined by American Parents Coalition’s Alleigh Marre, and The Washington Stand’s Joshua Arnold to discuss the new research and mentality shift we are seeing in the medical world.

The medical community is finally realizing that transgender surgeries are harming America's children. Recently, both the American Society of Plastic Surgeons and the American Medical Association released statements recommending gender-affirming surgeries be delayed until adulthood, but what does this mean for the issue as a whole? Is change happening? Host Casey Harper is joined by American Parents Coalition's Alleigh Marre, and The Washington Stand's Joshua Arnold to discuss the new research and mentality shift we are seeing in the medical world.

The medical community is finally realizing that transgender surgeries are harming America’s children. Recently, both the American Society of Plastic Surgeons and the American Medical Association released statements recommending gender-affirming surgeries be delayed until adulthood, but what does this mean for the issue as a whole? Is change happening? Host Casey Harper is joined by American Parents Coalition’s Alleigh Marre, and The Washington Stand’s Joshua Arnold to discuss the new research and mentality shift we are seeing in the medical world.

Dr. Tiffany Schatz of the Christian Medical and Dental Association addresses the recent settlement in a lawsuit by Fox Varian against doctors who did so-called gender reassignment surgery on her as a minor and the recent position statements by both The American Society of Plastic Surgeons and the American Medical Association questioning the wisdom of youth gender medical practices.  Rob Dayton, author of "100XLife: A Daily Practice," reminds us that just like our bodies need resistance and stress to strengthen, similarly God uses the adversities in our lives for growth if we are looking to Him and follow His ways.  Let's go to His gym! The Reconnect with Carmen and all Faith Radio podcasts are made possible by your support. Give now: Click here  

Rural Health News is a weekly segment of Rural Health Today, a podcast by Hillsdale Hospital. News sources for this episode: Kevin B. O'Reilly, “8 wins for doctors, patients in latest federal budget deal,” February 3, 2026, https://www.ama-assn.org/health-care-advocacy/federal-advocacy/8-wins-doctors-patients-latest-federal-budget-deal, American Medical Association. Selena Simmons-Duffin, “With an ACA fix uncertain in the Senate, Republicans replay old health care fights,” February 2, 2026, https://www.npr.org/2026/02/02/nx-s1-5695766/aca-enhanced-premium-subsidies-republicans-democrats, NPR. Shannon Schumaker, et al. “KFF Health Tracking Poll: Health Care Costs, Expiring ACA Tax Credits, and the 2026 Midterms,” January 29, 2026, https://www.kff.org/public-opinion/kff-health-tracking-poll-health-care-costs-expiring-aca-tax-credits-and-the-2026-midterms/, KFF Health News. Ashley Kirsinger, et al. “KFF Health Tracking Poll: Prior Authorizations Rank as Public's Biggest Burden When Getting Health Care,” February 2, 2026, https://www.kff.org/public-opinion/kff-health-tracking-poll-prior-authorizations-rank-as-publics-biggest-burden-when-getting-health-care/, KFF Health News. Paige Twenter, “A $20,500 cap on federal student loans will strain PA workforce: Survey,” February 4, 2026, https://www.beckershospitalreview.com/quality/hospital-physician-relationships/a-20500-cap-on-federal-student-loans-will-strain-pa-workforce-survey/, Becker's Hospital Review. Rural Health Today is a production of Hillsdale Hospital in Hillsdale, Michigan and a member of the Health Podcast Network. Our host is JJ Hodshire, our producer is Kyrsten Newlon, and our audio engineer is Kenji Ulmer. Special thanks to our special guests for sharing their expertise on the show, and also to the Hillsdale Hospital marketing team. If you want to submit a question for us to answer on the podcast or learn more about Rural Health Today, visit ruralhealthtoday.com.

1. SAVE America Act (Election Law & Voter ID) Core Argument The SAVE America Act would: Require proof of U.S. citizenship to register to vote Require photo ID to vote Democrats are portrayed as unanimously opposed, preventing passage due to the Senate’s 60‑vote threshold. Strategic Claim Cruz argues Republicans should: Force a “real” filibuster (continuous floor speeches) Make Democratic opposition politically and physically costly He frames Democratic resistance as intentional rather than procedural. Public Opinion Framing Polling is cited (CNN, Pew) to claim: Broad bipartisan and multiracial support for voter ID Democratic leadership (especially Chuck Schumer) is accused of ignoring their own voters. 2. Voter Fraud & Ballot Harvesting Claims Presented Ballot harvesting is described as: A system that enables fraud, especially among elderly or vulnerable populations Democrats are accused of: Supporting policies that increase fraud opportunities Reversing recommendations from the Carter–Baker Commission There is justification for: Photo ID laws Restrictions on mail-in voting Limits on third-party ballot collection 3. Somali Welfare Fraud in Minnesota Central Allegation Massive welfare fraud in Minnesota tied to programs serving the Somali immigrant community. Figures cited include: Up to half of $18 billion in welfare spending allegedly lost to fraud Disproportionately high welfare participation rates among Somali households Democratic state officials are accused of: Knowing about the fraud Allowing it to continue for political gain Silencing whistleblowers Stolen welfare funds indirectly finance al‑Shabab, a terrorist organization 4. Medical Policy Shift on Gender Surgeries for Minors Key Development The American Society of Plastic Surgeons and the American Medical Association are described as: Reversing prior support for “gender‑affirming surgeries” for minors Now recommending deferral until adulthood Causal Explanation The reversal is attributed to: A high‑profile malpractice lawsuit by a detransitioner Legal and financial risk to medical institution Please Hit Subscribe to this podcast Right Now. Also Please Subscribe to the 47 Morning Update with Ben Ferguson and The Ben Ferguson Show Podcast Wherever You get You're Podcasts. And don't forget to follow the show on Social Media so you never miss a moment! Thanks for Listening YouTube: https://www.youtube.com/@VerdictwithTedCruz/ Facebook: https://www.facebook.com/verdictwithtedcruz X: https://x.com/tedcruz X: https://x.com/benfergusonshowYouTube: https://www.youtube.com/@VerdictwithTedCruzSee omnystudio.com/listener for privacy information.

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from January 31-February 6, 2026.

This is a 2-part episode: From a December 2025 WEDI virtual spotlight, a panel of health IT leaders break down the current state and the future of regarding information blocking, and how organizations can stay compliant while moving interoperability forward. The panel: Rebekah Fiehn, Strategic Partnership Developer, American Dental Association Andrew Tomlinson, Senior Director, Regulatory & International Affairs, AHIMA Arna Meyer, Technical Product Manager, Stedi Alisa Kuehn, VP, General Counsel & Privacy Officer, Indiana Health Information Exchange Chelsea Arnone, Director, Federal Affairs, CHIME Sasha TerMaat, EHRA's Information Blocking Compliance Task Force The moderator is Jeff Coughlin, Director, Federal Affairs, American Medical Association

TDC Podcast topics - Ryan Routh, the dork who tried to assassinate Trump finds out his fate, dad finds out his kids middle school took him out to protest ICE and he's pissed, what's going on with the Marxist teachers union these days?  Amy has a new theory on the Karen Read story, the American Medical Association reverses course on trans surgeries, landmark judgement awards $2M to a detransitioner in a malpractice lawsuit, the first of MANY hopefully, it doesn't sound like good news regarding the health of Lions safety Kerby Joseph and his bad knee, email and much more.

4:20 pm: Josh Findlay, Director of the National Election Protection Project at the Texas Public Policy Foundation, joins the show for a conversation about in piece in Townhall about why America should use voter ID.4:38 pm: Senator Chris Wilson joins the program to discuss why the Utah Legislature is working so hard on judicial transparency during the current session and responds to criticism from the state's bar association.6:05 pm: Representative Paul Cutler joins Rod and Greg for a conversation about his proposed legislation to require people gathering signatures for a ballot initiative to undergo government training about what they must tell voters.6:38 pm: Dr. Kurt Miceli, Chief Medical Officer for Do No Harm, joins the show to discuss how the American Medical Association has now followed the American Society of Plastic Surgeons in condemning gender-affirming surgeries on children under 19 years of age.

Josh opens the show by breaking down a major ruling that truly “follows the science,” as the American Medical Association backs off its previous support for sex-change procedures for minors. He explains what this shift means for the broader movement—and where the fight goes from here. Next, Josh dives into the latest census numbers and why blue states could be in serious trouble moving forward. He lays out how population changes are reshaping the Electoral College map—and why Democrats may soon be forced to confront some hard truths about the country they claim to represent. Josh then turns to the newest developments in the Jeffrey Epstein case, warning that anyone hoping for real accountability or justice may be disappointed by what ultimately comes out. To close, Josh discusses the SAVE Act and why Democrats are once again landing on the wrong side of public opinion—especially on voter ID, where a strong majority of Americans, including Democrats and Republicans alike, believe showing ID to vote is simply common sense.See omnystudio.com/listener for privacy information.

In this powerful episode of The Whole Body Detox Show, host David DeHaas of Living Waters Wellness Center sits down with Dr. Ann Hester, board-certified internal medicine physician and lifestyle medicine expert, to expose the hidden role of toxins, plastics, and modern living in today's chronic disease epidemic.Dr. Hester breaks down the six pillars of lifestyle medicine, a science-backed framework now endorsed by the American Medical Association, and explains how these pillars can help prevent, treat, and even reverse conditions like type 2 diabetes, inflammation, cardiovascular disease, dementia, and cancer risk.In this episode, you'll discover:What the six pillars of lifestyle medicine really are and why they matterHow plastics, microplastics, endocrine disruptors, and household chemicals impact hormones and inflammationWhy food preparation methods (high heat, frying, charring) create toxic compounds like AGEsHow sleep, stress, movement, and human connection directly affect healing and disease reversalPractical ways to reduce toxic exposure in food, water, cookware, personal care products, and packagingWhy whole-food, plant-predominant nutrition is foundational for long-term healthThe difference between lifespan vs healthspan and how to protect your brain and vitalityThis episode connects modern medical science with real-world detox strategies, showing how small daily changes can dramatically shift health outcomes. If you're serious about reducing inflammation, avoiding unnecessary medications, and reclaiming your health naturally, this is a must-listen conversation.Ready to reduce inflammation and detox your body naturally?Visit livingwaterscleanse.com to watch the Four Natural Laws of Healing video, explore real success stories, or call 208-378-9911 to learn whether colon hydrotherapy or the 10-Day Healing Retreat is right for you.If this episode helped you, leave a Google review and share the one thing you learned from today's show.Listen to the Whole Body Detox Show on all major podcast platforms and take the next step toward lasting health.Support the show Ready for your healing journey?Visit our website: www.LivingWatersCleanse.com Or give us a call at: (208) 378-9911Stem Cell Activation Patches:www.StemCellPatch.netGet your Supplements and Natural Body Products Here:www.livingwaterscleanse.com/supplementsQI-Shield EMF Devices:Protect your whole home or office with a touric shield from EMF's. 1. QI Shield Covers 16'x16' 2. QI Home Covers 50' x 50' 3. QI Max Covers 250'x250'Click on link and enter Livingwaters in discount code section during checkout Magnesium Soaks:Follow us on our socials: Living Waters Wellness CenterBitChute: www.bitchute.com/livingwaterswellnessRumble: www.rumble.com/l...

This week, we're in Pennsylvania discussing the Bucks County Killings. Then we'll talk about the murder of a young mother. Buckle up and join us on this dark and twisted ride through the Keystone State. Be sure to subscribe on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and leave a review, or email us at unitedstatesofmurder@gmail.comFollow us on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠!Sources: ⁠July 2017 Pennsylvania Murders (Wiki), Philly Burbs, American Medical Association, The Lost Boys of Bucks County, Cosmo DiNardo Philly Mag, People Mag, Murder of Rebekah Byler, ABC NewsMusic by ⁠⁠⁠⁠⁠⁠⁠Pixabay⁠

We have learned a lot about extended spectrum coverage of prophylactic antibiotics for cesarean section. The landmark C/SOAP trial randomized 2,013 women undergoing nonelective cesarean delivery to azithromycin 500 mg IV plus standard prophylaxis versus placebo, demonstrating a 51% reduction in the composite outcome of endometritis, wound infection, or other infection. Adjuvant Zmax (plus standard first-generation cephalosporin) is now recognized as evidence-based antibiotic coverage for intrapartum cesarean, cesarean with ruptured membranes, and patients with obesity. This last patient characteristic comes from the ERAS latest update. But what is ZMAX is not available? Is there an evidence-based peri-op alternative in these cases? Does Gent and Clinda cover mycoplasma/Ureaplasma? What about postop flagyl? Listen in for details. 1. Tita AT, Szychowski JM, Boggess K, et al. Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. The New England Journal of Medicine. 2016. 2. Yang M, Yuan F, Guo Y, Wang S. Efficacy of Adding Azithromycin to Antibiotic Prophylaxis in Caesarean Delivery: A Meta-Analysis and Systematic Review. International Journal of Antimicrobial Agents. 2022. 2. ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery. Obstetrics and Gynecology. 2018. Committee on Practice Bulletins-Obstetrics 3. Martingano D, Nguyen A, Nkeih C, Singh S, Mitrofanova A. Clarithromycin Use for Adjunct Surgical Prophylaxis Before Non-Elective Cesarean Deliveries to Adapt to Azithromycin Shortages in COVID-19 Pandemic. PloS One. 2020. 4. Valent AM, DeArmond C, Houston JM, et al. Effect of Post–Cesarean Delivery Oral Cephalexin and Metronidazole on Surgical Site Infection Among Obese Women: A Randomized Clinical Trial. The Journal of the American Medical Association. 2017. 5. Wood, G. E., et al. "In Vitro Susceptibility of Mycoplasma genitalium to Nitroimidazoles." Antimicrobial Agents and Chemotherapy 6. https://www.cdc.gov/std/treatment-guidelines/mycoplasmagenitalium.htm

In 1994, Oregon voters passed the Death with Dignity Act, which legalized physician-assisted suicide for the terminally ill. Since then, it has become legal in 4 more states, including New Mexico, where the state court ruling that it is constitutional is under appeal. Is it, in the words of the American Medical Association's code of ethics, "fundamentally incompatible with the physician's role as healer"? Will these laws lead to a slippery slope, where the vulnerable are pressured to choose death and human life is devalued? Or do we need to recognize everyone's basic right to autonomy, the right to end pain and suffering, and the right to choose to die with dignity? ARGUING YES: Peter Singer: Co-Founder of the Effective Altruism movement; Author of “The Most Good You Can Do" Andrew Solomon: Author of “Far From the Tree”, Professor of Clinical Psychology at Columbia University ARGUING NO: Baroness Ilora Finlay: President of the British Medical Association, Member of the House of Lords Daniel Sulmasy: Prof. of Medicine and Ethics at University of Chicago, Member of the Presidential Bioethics Commission Emmy award-winning journalist John Donvan moderates  Join the conversation on our Substack—share your perspective on this episode and subscribe to our weekly newsletter for curated insights from our debaters, moderators, and staff. Follow us on YouTube, Instagram, LinkedIn, X, Facebook, and TikTok to stay connected with our mission and ongoing debates. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from January 24-30, 2026.

Linda Brubaker, MD, and Christopher C. Muth, MD, Deputy Editors of JAMA, the Journal of the American Medical Association, discuss articles published from January 17-23, 2026.

Episode Summary By Concierge Medicine Today JANUARY 2026 - Concierge medicine and direct primary care didn't just grow — they surged more than 80% in five years. Headlines are spinning this as a threat to access and equity. But is that the full story? In this episode, the Editor-In-Chief of the industry's trade publication, Concierge Medicine Today, author and Host, Michael Tetreault, breaks down the latest national research and explains what's really happening beneath the surface. This isn't about luxury medicine. It's about physician burnout, broken reimbursement models, administrative overload, and doctors quietly redesigning their careers to survive. You'll hear why this shift is less about "escaping responsibility" and more about reclaiming sustainability, why corporate ownership is rising fast, and why concierge medicine didn't create the primary care shortage — it exposed it. If you care about the future of medicine, physician retention, and building healthcare that actually works, this conversation matters.

To unpack this, John Maytham is joined by Tayla du Plessis, Dietician at the Sports Science Institute of South Africa, who helps us understand why BMI can be misleading for some people, and where it still plays a useful role. While organisations like the American Medical Association acknowledge BMI’s limitations, they also stress that it remains a helpful screening tool when used alongside other health indicators — not in isolation. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from January 10-16, 2026.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into a landscape marked by rapid transformations and strategic maneuvers that are reshaping the industry.Novo Nordisk is at a pivotal point under the leadership of CEO Maziar Mike Doustdar. The company is navigating a significant transition, focusing on reclaiming its leadership in the glucagon-like peptide-1 (GLP-1) market. This is crucial as GLP-1 receptor agonists are central to diabetes and obesity treatments, areas where Novo Nordisk aims to solidify its presence amidst fierce competition.AstraZeneca is setting ambitious targets, aiming for $80 billion in revenue by 2030. Their confidence is buoyed by strong Phase 3 clinical trial performances, particularly in oncology and rare diseases, underscoring the importance of a robust and successful pipeline. AstraZeneca's acquisition of Modella AI marks an integration of advanced AI models into oncology R&D operations, aligning with industry trends leveraging AI for drug discovery processes. By incorporating AI technologies, AstraZeneca aims to revolutionize precision medicine approaches within oncology treatments.Travere Therapeutics finds itself at a critical juncture with the FDA's delayed decision on Filspari (sparsentan) for focal segmental glomerulosclerosis (FSGS). This potential approval could tap into a significant market opportunity, but the delay highlights regulatory challenges that can impact timelines and revenue forecasts.Gilead Sciences continues to strengthen its position in HIV treatment with lenacapavir's approval for bi-annual dosing. This advancement not only enhances patient compliance but also positions Gilead advantageously for strategic partnerships. Their strategic positioning post-approval of lenacapavir for HIV prevention marks a milestone, emphasizing innovation's role in drug formulations.Leo Pharma's pursuit of partnerships in rare dermatological diseases reflects a broader trend towards specialization and diversification into niche markets. Meanwhile, Ionis Pharmaceuticals is gearing up to launch Tryngolza (olezarsen) for new indications, doubling their sales projections and demonstrating confidence in their RNA-targeted therapy.Caldera's emergence with significant funding points to ongoing investor interest in innovative biotech ventures, particularly those involving cross-border collaborations like their licensed drug from China for inflammatory bowel disease. Cross-border collaborations such as Caldera's venture into inflammatory bowel disease treatments are becoming more prevalent, integrating innovations from different regions to accelerate novel therapy availability for complex diseases.Illumina's efforts to navigate export challenges with China highlight geopolitical factors influencing biotech operations and global supply chains. They are actively working to stabilize their business environment while supporting academic research initiatives. Illumina's collaboration efforts with China amidst geopolitical tensions further demonstrate complexities within international trade relations affecting scientific collaborations.The American Medical Association's investment in "precision education" using data analytics exemplifies how technology is reshaping healthcare education and practice, aiming to enhance outcomes by tailoring learning experiences.AbbVie has committed $100 billion to U.S. research and development over the next decade, focusing on biologics and autoimmune disorders. This substantial investment underscores their commitment to innovation while seeking competitive edge enhancements through tariff exemptions.On clinical fronts, significant advancements are being made in therapies targeting rare diseases such as Sentynl Therapeutics' FDA approval for Zycubo—a novel protein therapy addressing Menkes disease—highlightSupport the show

Andrew Humberman BioSnap a weekly updated Biography.Andrew Huberman, the Stanford neuroscientist and Huberman Lab podcast powerhouse, has been lighting up timelines and headlines with his signature blend of brain science and no-nonsense health advice over the past few days. Fox News reports he jumped into the nutrition wars by endorsing the Trump administrations bold new food pyramid on X, praising its meat-and-fats-at-the-top rethink as spot on if you tweak it with more veggies and low-sugar ferments like sauerkraut, while confessing his aversion to shrimp and milk. This nod to HHS Secretary Robert F Kennedy Jrs Make America Healthy Again push drew cheers from experts like ex-FDA commissioner David Kessler and the American Medical Association, positioning Huberman as a key voice in the real food revolution thats already sparking policy buzz with potential to reshape American diets long-term.Hot on its heels, Huberman dropped a marathon guest episode on January 12 titled How to Overcome Addiction to Substances or Behaviors with Stanford psychiatrist Dr Keith Humphreys, diving deep into everything from psychedelics and ibogaine to AA meetings, social media traps, and GLP-1 drugs for booze cravings, as detailed on the Huberman Lab site. Its a timely powerhouse amid rising addiction talks, blending hard science with practical tools that could influence recovery protocols nationwide.On the personal front, Prismedia ai spotlighted Hubermans latest health routine reveal, where he demystified cold plunges as a morning mood-and-focus booster timed to cortisol spikes, but just one arrow in a quiver stocked with freebies like sunlight and movementno ice bath dogma required. Earlier in the week, around January 6, Hindustan Times covered his Instagram viral on a 90-year-old grandpas flawless 20 push-ups, crediting lifelong daily effort, family joy, and a fun-hard-work mindset from colleague Dr Alia Crum. No confirmed public appearances or business moves popped up, but his X posts and podcast dominance keep the gossip mills churning on whether hes eyeing that Protocols book preorder for a wellness empire expansion. All verified from these outlets; nothing speculative herejust Huberman owning the health convo like always.Get the best deals https://amzn.to/3ODvOtaThis content was created in partnership and with the help of Artificial Intelligence AI

I don't have to remind anyone who listens to this podcast that the cost of MS disease-modifying therapies is obscenely high. And we're not just talking about relatively new medications. Older medications -- some decades old -- continue to increase in price without any rational explanation for why or how.   On January 2nd, we lost a true warrior in the ongoing battle to lower the price of prescription drugs when David Mitchell, the founder of Patients for Affordable Drugs, passed away.   I met David in 2018 at a National MS Society Public Policy Conference, and he was a guest on Episode 31 of RealTalk MS.  This week, I'm re-sharing the conversation we had in 2018. We'll also tell you about an international workshop that represents the initial steps in developing a global research agenda to end MS. We're explaining how AI is about to have a major impact on healthcare. And we'll share the American Medical Association's brief to Congress, making the case for extending access to telehealth. We have a lot to talk about! Are you ready for RealTalk MS??! This Week: We're remembering David Mitchell  :22 The first steps toward a global research agenda to prevent MS were just published  1:02 Doctor AI will see you now  5:45 The American Medical Association asks lawmakers to extend access to telehealth  10:27 David Mitchell in his own words  12:41 Share this episode  27:56 Next week  28:16 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/437 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Patients for Affordable Drugs https://patientsforaffordabledrugs.org PAPER: Toward a Global Research Agenda for Preventing Multiple Sclerosis https://journals.sagepub.com/doi/10.1177/13524585251398381 AMA BRIEF: The Case for Permanent Telehealth Policy and Expanded Access to Virtual Care https://ama-assn.org/system/files/issue-brief-telehealth-policy-expanded-access-to-virtual-care.pdf ChatGPT Health https://openai.com/index/introducing-chatgpt-health JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 437 Guests: David Mitchell Privacy Policy

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from January 3-9, 2026.

Dr. Travis Morrell, chair of Colorado Principled Physicians and a senior fellow at Do No Harm Medicine, joins me to pull back the curtain on what he calls the "medical mafia"—the intricate web of organizations led by the American Medical Association that manufactures the illusion of consensus on controversial medical practices, particularly pediatric sex trait modification.We explore how the AMA maintains its power despite only 15% of American doctors being members. The answer lies in a government-mandated monopoly: the AMA holds the copyright on CPT codes—the procedural codes every healthcare provider in the country must use to bill insurance and Medicare. This generates hundreds of millions in revenue annually, which the AMA then uses to lobby politicians, influence other medical organizations, and train activists within specialty societies to align with their positions.Travis explains how this money flows into shadow organizations like Race Forward to push diversity, equity, and inclusion initiatives that ultimately tie back to gender ideology in medicine. We discuss the physical harms of cross-sex hormones on women—including vaginal atrophy, pelvic floor dysfunction, and incontinence affecting over 95% of female patients on testosterone—and why Travis compares these effects to female genital mutilation. We also discuss what everyday people and physicians can do to push back against this institutional capture, and why speaking up—even privately—is a moral duty.Travis Morrell, MD, MPH, is a dad, husband, and physician. A lifelong learner to a fault, his postgraduate medical training in five specialty departments and medical leadership gives him a broad perspective of his profession. He is published in the top journals of multiple fields and in popular media. Dr. Morrell is a Senior Fellow at Do No Harm Medicine. He is Chair of Colorado Principled Physicians, a grassroots organization of physicians promoting evidence-based medicine and classical liberal values.The X thread mentionedX: @MorrellMDmphProtect Kids ColoradoColorado Principled PhysiciansStop the Harm Database[00:00:00] Start[00:00:46] Introducing Dr. Travis Morrell[00:09:30] The AMA's $450 Million Empire and CPT Code Monopoly[00:17:34] How the AMA Controls Other Medical Organizations[00:30:53] Who's Driving the Gender Ideology Agenda[00:44:35] Cross-Sex Hormones as Female Genital Mutilation[00:49:06] Physical Harms of Testosterone on Women[01:07:01] What Doctors and Patients Can Do[01:10:51] Why Doctors Alone Won't Save the Day[01:17:43] Compassion for Affected Kids and Families[01:18:47] Where to Find Dr. Travis MorrellROGD REPAIR Course + Community gives concerned parents instant access to over 120 lessons providing the psychological insights and communication tools you need to get through to your kid. Now featuring 24/7 personalized AI support implementing the tools with RepairBot! Use code SOMETHERAPIST2026 to take 50% off your first month.PODCOURSES: use code SOMETHERAPIST at LisaMustard.com/PodCoursesTALK TO ME: book a meeting.PRODUCTION: Looking for your own podcast producer? Visit PodsByNick.com and mention my podcast for 20% off your initial services.SUPPORT THE SHOW: subscribe, like, comment, & share or donate.Watch NO WAY BACK: The Reality of Gender-Affirming Care. Use code SOMETHERAPIST to take 20% off your order.MUSIC: Thanks to Joey Pecoraro for our song, “Half Awake,” used with gratitude & permission.ALL OTHER LINKS HERE. To support this show, please leave a rating & review on Apple, Spotify, or wherever you get your podcasts. Subscribe, like, comment & share via my YouTube channel. Or recommend this to a friend!Learn more about Do No Harm.Take $200 off your EightSleep Pod Pro Cover with code SOMETHERAPIST at EightSleep.com.Take 20% off all superfood beverages with code SOMETHERAPIST at Organifi.Check out my shop for book recommendations + wellness products.Show notes & transcript provided with the help of SwellAI.Special thanks to Joey Pecoraro for our theme song, “Half Awake,” used with gratitude and permission.Watch NO WAY BACK: The Reality of Gender-Affirming Care (our medical ethics documentary, formerly known as Affirmation Generation). Stream the film or purchase a DVD. Use code SOMETHERAPIST to take 20% off your order. Follow us on X @2022affirmation or Instagram at @affirmationgeneration.Have a question for me? Looking to go deeper and discuss these ideas with other listeners? Join my Locals community! Members get to ask questions I will respond to in exclusive, members-only livestreams, post questions for upcoming guests to answer, plus other perks TBD. ★ Support this podcast on Patreon ★

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from December 20,2025, through January 2, 2026.

We begin with an exclusive interview with the sunburned sisters whose airport meltdown went viral. It's definitely not a situation you want to run into during your holiday vacation. Two sisters. getting arrested after a gate agent told cops one of them pushed her down. The sisters speak about what they say really happened. And traveling during the holidays is hard enough - along with worrying about severe winter weather, and all the germs, there's this - trying to keep your suitcase from getting stolen. As Les Trent reports, just as the numbers of travelers have gone up, so have the number of thefts. Plus, pickleball peril - as the sport's popularity continues to soar comes a warning. A new study by the American Medical Association finds more and more people are going to the ER with eye injuries.  Alison Hall with what you need to know. And the U.S. Surgeon General recently issued a major new advisory warning that drinking alcohol can increase your risk of getting cancer. The news comes as "Dry January" - the challenge of giving up drinking for the first month of the New Year - is growing in popularity.   To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Today's podcast is titled “The Evolution of Socialized Medicine: Health Care Reform Today.” Recorded in 1994, Dennis McCuistion, former Clinical Professor of Corporate Governance and Executive Director of the Institute for Excellence in Corporate Governance at the University of Texas at Dallas, past president of the American Medical Association and World Medical Association and author of Code Blue: Health Care in Crisis Dr. Edward Annis and Commissioner of the Texas Department of Health, board-certified pediatrician Dr. David Smith discuss the need for public health infrastructure, tort reform, and the role and effectiveness of government versus market-based solutions. Listen now, and …

A CDC panel recently reversed a decades-old recommendation that all babies in the U.S. receive the hepatitis B vaccine at birth. Medical groups, including the Chicago-based American Medical Association, have denounced the new recommendations, calling them “reckless.” In the Loop talks about what this means for Illinois kids and families with Dr. Steven Flamm, hepatologist and professor of Medicine at Rush University and Dr. Marielle Fricchione, pediatrician and chair of the Illinois Immunization Advisory Committee. For a full archive of In the Loop interviews, head over to wbez.org/intheloop.